The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
The Food and Drug Administration (FDA) recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results